Drug Information

Drug General Information
Drug ID
D03REA
Former ID
DNC009120
Drug Name
5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Formula
C18H16O4
Canonical SMILES
COC1=CC=CC=C1CC2=CC3=C(C=CC=C3OC)OC2=O
InChI
1S/C18H16O4/c1-20-15-7-4-3-6-12(15)10-13-11-14-16(21-2)8-5-9-17(14)22-18(13)19/h3-9,11H,10H2,1-2H3
InChIKey
PUMXCXWQMAPHFQ-UHFFFAOYSA-N
PubChem Compound ID
44592117
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
Cannabinoid receptor 2 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.